FOLLITROPIN ALFA LUTROPIN ALFA

Follitropin alfa and Lutropin alfa are recombinant hormones used in the treatment of infertility. Follitropin alfa is a manufactured version of follicle-stimulating hormone (FSH), which stimulates the ovaries to produce eggs in women and enhances sperm production in men. Lutropin alfa is a manufactured version of luteinizing hormone (LH), used primarily alongside FSH in women with significantly low natural levels of these hormones to support the development of healthy eggs for pregnancy. Both hormones are utilised in fertility treatments including IVF. Follitropin alfa received approval in Europe in 1995 and subsequently in the United States in 1997. Lutropin alfa was approved in Europe in 2000, primarily for women with severe LH and FSH deficiency. Lutropin alfa is not approved for use in the United States. These medicines have improved the safety, consistency, and effectiveness of fertility treatments in comparison to earlier hormone therapies.

Follitropin alfa and Lutropin alfa is used to treat: Treatment of female infertility caused by severe deficiency of LH and FSH (hypogonadotropic hypogonadism). Helps stimulate the growth and development of ovarian follicles in women who do not ovulate naturally. Used during assisted reproductive techniques (ART) like IVF (In-Vitro Fertilisation) to improve follicle development. Supports hormone balance in women with underactive pituitary function. Promotes ovulation in women who have not responded well to FSH treatment alone.

Common (usually mild and temporary): Mild abdominal pain or bloating. Headache. Nausea. Breast tenderness. Injection site reactions (redness, swelling, or itching). Serious (less common, seek medical help): Ovarian Hyperstimulation Syndrome (OHSS) — symptoms include severe abdominal pain, swelling, rapid weight gain, or shortness of breath. Blood clots — signs include leg pain or swelling, chest pain, or difficulty breathing. Allergic reactions — rash, itching, swelling of face/lips, or difficulty breathing. Ovarian cyst rupture (rare). Ectopic pregnancy (pregnancy outside the womb, rare but serious) Most people tolerate the medicine well, but any unexpected or worsening symptoms should be reported right away.

Risk of Multiple Pregnancies – Using this treatment increases the chance of twins or more, which can lead to pregnancy complications. Possible Allergic Reactions – Serious allergic reactions, such as rash, swelling, or breathing problems, can occur. Seek urgent care if these symptoms develop. Blood Clot Risk – Fertility treatments can increase the risk of blood clots; inform your doctor if you have a history of clots. Not for Use During Pregnancy – These drugs are meant to help you get pregnant but should not be used once pregnancy is confirmed. Injection Site Reactions – Redness, pain, or swelling can occur at the injection site; proper injection technique helps reduce this risk.

Use Under Specialist Care Only – Follitropin alfa and Lutropin alfa should only be used under the supervision of a fertility doctor, with regular monitoring. Do Not Self-Adjust Dose – Never change your dosage or injection schedule without your doctor’s advice, as incorrect use can lead to serious side effects. Monitor for Ovarian Hyperstimulation Syndrome (OHSS) – There is a risk of OHSS, a condition where the ovaries become swollen and painful; seek immediate help if you experience severe abdominal pain or rapid weight gain. Not for Use in Certain Conditions – These medicines should not be used if you have unexplained vaginal bleeding, ovarian cancer, or other hormone-related tumours. Inform Doctor About Other Health Issues – Tell your doctor if you have thyroid, adrenal, or pituitary gland problems, as they may need to be treated before starting this medication.

National library of medicine Gentamicin.Bruno J. Chaves; Prasanna Tadi https://www.ncbi.nlm.nih.gov/books/NBK557550/ Gentamicin -uses, side effects,and more https://www.webmd.com/drugs/2/drug-1496/gentamicin-injection/details Experimental gentamicin nephrotoxicity and agents that modify it: a mini-review of recent research https://onlinelibrary.wiley.com/doi/10.1111/j.1742-7843.2011.00728.x Gentamicin induced correction of CFTR function in patients with cystic fibrosis CFTR stop mutations https://www.nejm.org/doi/full/10.1056/NEJMoa022170 Antifungal Activity of Gentamicin B1 against Systemic Plant Mycosesby Gaspar Banfalvi https://www.mdpi.com/1420-3049/25/10/2401\